Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 5/20 | 0.37 |
| ▸ | CES1 | P23141 | 5/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.37 |
| ▸ | FABP3 | P05413 | 5/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioglycolic Acid SCHEMBL33524891 | 0.92 | CES2 (0.41) | CA1CES2CES1FABP3CA2 | |
| Thioglycolic Acid SCHEMBL746612 | 0.84 | CA1 (0.44) | CA1CES2CES1FFAR3HDAC3 | |
| Thioglycolic Acid SCHEMBL6365844 | 0.77 | CES2 (0.43) | CA1CES2CES1FABP3CA2 | |
| Thioglycolic Acid SCHEMBL7654255 | 0.77 | CES2 (0.43) | CA1CES2CES1FABP3CA2 | |
| Thioglycolic Acid SCHEMBL1487513 | 0.75 | CA4 (0.39) | CA1FFAR3HDAC3HDAC1HDAC2 | |
| SCHEMBL2348418 | 0.75 | TSHR (0.38) | CES2CES1 | |
| Thioglycolic Acid SCHEMBL7700486 | 0.73 | CA1 (0.46) | CA1CES2CES1FFAR3HDAC3 | |
| Hydrochloric Acid SCHEMBL11682272 | 0.72 | — | — | |
| Fumaric Acid SCHEMBL11672387 | 0.72 | FABP3 (0.39) | CA1CES2CES1FABP3 | |
| Tetrabuthylammonium SCHEMBL7193259 | 0.71 | SLC22A1 (0.55) | CA1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729526-A2 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | Galata Chemicals, LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | GALATA CHEMICALS LLC (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092210-A1 | BIS(ALKYLTIN MERCAPTIDES) AND THEIR USE AS HEAT STABILIZERS | MGMT, TST, MPST | CA1 2427/4885CES2 279/4885CES1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.